Search results for "030211 gastroenterology & hepatology"

showing 10 items of 1275 documents

Is elimination of HCV in 2030 realistic in Central Europe.

2021

According to the recent data presented by Central-European HCV experts, the estimated prevalence of HCV is between 0.2% and 1.7% in certain countries in this region. There are no financial limitations to access to treatment in most countries. Patients in these countries have access to at least one pangenotypic regimen. The most common barriers to the elimination of HCV in Central Europe are a lack of established national screening programmes and limited political commitment to the elimination of HCV. Covid-19 has significantly affected the number of patients who have been diagnosed and treated, thus, delaying the potential elimination of HCV. These data suggest that the elimination of HCV e…

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Hepatitis C virusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)medicine.disease_causeAntiviral Agents03 medical and health sciences0302 clinical medicineEpidemiologymedicinePrevalenceHumansHepatologybusiness.industrySARS-CoV-2virus diseasesCOVID-19Hepatitis Cmedicine.diseaseVirologyHepatitis Cdigestive system diseasesHcv eliminationEuropeRegimen030220 oncology & carcinogenesis030211 gastroenterology & hepatologybusinessLiver international : official journal of the International Association for the Study of the LiverREFERENCES
researchProduct

Caveats in interpreting SARS‐CoV‐2 IgM + /IgG − antibody profile in asymptomatic health care workers

2020

Serological testing is increasingly recognized as a useful tool for management of the COVID‐19 pandemic.1 Cross‐sectional serosurveys provide information on exposure levels in a target population, which is helpful for designing public health strategies to blunt community transmission.2 This article is protected by copyright. All rights reserved.

medicine.medical_specialty2019-20 coronavirus outbreakbusiness.industryPublic healthSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Target populationAsymptomaticVirology03 medical and health sciences0302 clinical medicineInfectious DiseasesAntibody ProfileVirologyHealth caremedicine030211 gastroenterology & hepatology030212 general & internal medicinemedicine.symptomSeroconversionbusinessIntensive care medicineJournal of Medical Virology
researchProduct

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease.

2019

Background & Aim There is an unmet need for non-invasive biomarkers in non-alcoholic fatty liver disease (NAFLD) that can diagnose advanced disease and identify patients suitable for clinical trials. The PRO-C3 collagen neo-epitope is a putative direct marker of fibrogenesis. We assessed the performance of PRO-C3 in a large, well-characterised international NAFLD cohort and report the development and validation of 2 novel panels for the diagnosis of advanced fibrosis (F≥3) in NAFLD, including a simplified clinical score which eliminates the need for online calculators. Methods Plasma PRO-C3 levels were determined in a prospectively recruited international cohort of 449 patients with biopsy …

medicine.medical_specialtyADVANCED FIBROSISSCORING SYSTEMPROGRESSIONGastroenterologySTEATOHEPATITIS03 medical and health sciences0302 clinical medicineFibrosisInternal medicineNAFLDBiopsyInternal MedicineImmunology and AllergyMedicineSTEATOSISPRO-C3Stage (cooking)lcsh:RC799-869030304 developmental biologySteatohepatitisRISK0303 health sciencesScience & TechnologyHepatologymedicine.diagnostic_testGastroenterology & Hepatologybusiness.industryFatty liverfibrosisGastroenterologyNASHDIABETES-MELLITUSCHRONIC HEPATITISBiomarkermedicine.disease3. Good healthClinical trialCohortBIOPSYBiomarker (medicine)030211 gastroenterology & hepatologylcsh:Diseases of the digestive system. GastroenterologySteatohepatitisbusinessLife Sciences & BiomedicineResearch ArticleJHEP reports : innovation in hepatology
researchProduct

Composite femoro-tibial bypass as alternative solution in complicated revascolarization: Case report

2021

Introduction Peripheral Arterial Disease (PAD) in diabetic patients is a significant cause of Morbility. Long arterial occlusion in patient previously treated can require unusual and complex solution. Herein we report a case of complicated bypass in diabetic patient with history of bypass for bilateral popliteal aneurysm. Presentation of case A 51-year-old male, smoker, with hypertension and diabetes mellitus was referred to our hospital for rest pain in left limb and peripheral cyanosis. Ultrasound doppler (US) showed an occlusion after common femoral artery with patency of Anterior-tibial artery (ATA) two centimeters after the origin. The unavailability of adequate autologous conduit nece…

medicine.medical_specialtyATA anterior-tibial arterymedicine.medical_treatmentDFA deep femoral arteryCase ReportFemoral arterySettore MED/22 - Chirurgia VascolareCLI critical limb ischemiaPopliteal aneurysmPTA posterior tibial artery03 medical and health sciences0302 clinical medicinePAD peripheral arterial diseasemedicine.arteryAngioplastySFA superficial femoral arteryOcclusionmedicineCFA common femoral arteryVeinUS ultrasound dopplerbusiness.industryCritical limb ischemiaCritical limb ischemiaComposite distal bypassArterial occlusionSurgerymedicine.anatomical_structure030220 oncology & carcinogenesisRedo perpheral surgery030211 gastroenterology & hepatologySurgerymedicine.symptombusinessArteryInternational Journal of Surgery Case Reports
researchProduct

Optimizing the use of linaclotide in patients with constipation-predominant irritable bowel syndrome : an expert consensus report

2017

INTRODUCTION: Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by chronic or recurrent abdominal pain in association with defecation or a change in bowel habits. A predominant disorder of bowel habits, IBS is classified into three main subtypes: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D) and IBS alternating between constipation and diarrhea (IBS-M). Linaclotide is a first-in-class, oral, once-daily guanylate cyclase-C receptor agonist (GC-CA) that is licensed for the symptomatic treatment of moderate-to-severe IBS-C in adults. This review aims to facilitate and optimize clinical practices, establishing common guidelines to monitor patie…

medicine.medical_specialtyAbdominal painAbdominal painConstipationReviewRecommendationsGastroenterologyIrritable Bowel Syndrome03 medical and health scienceschemistry.chemical_compound0302 clinical medicineBloatingGastrointestinal AgentsInternal medicinemedicineHumansPharmacology (medical)030212 general & internal medicineLinaclotideGastroenterologiaIrritable bowel syndromeMedicine(all)business.industryBloatingGastroenterologyIntestins -- MalaltiesGeneral Medicinemedicine.diseaseSíndrome do Intestino IrritávelRheumatologyDiarrheaTreatment OutcomechemistryDefecationLinaclotide030211 gastroenterology & hepatologyPatient managementmedicine.symptomConstipation-predominant irritable bowel syndromebusinessPeptidesReceptors Atrial Natriuretic FactorConstipation
researchProduct

Mirizzi syndrome type V complicated with both cholecystobiliary and cholecystocolic fistula: a case report

2021

Abstract Mirizzi syndrome (MS) is a common bile duct (CBD) obstruction caused by extrinsic compression from an impacted stone in the cystic duct or infundibulum of the gallbladder. Patients affected by MS may present abdominal pain and jaundice. A 37-year-old male with neurologic residuals post-encephalitis arrived at the emergency department reporting abdominal pain, jaundice and fever. An ultrasound of the abdomen identified cholecystolithiasis with a dilated CBD. He did not undergo CT or MRI due to poor compliance and parents’ disagreement. Eventually, they accepted to perform endoscopic retrograde cholangiopancreatography, which diagnosed MS with both cholecystobiliary and cholecystocol…

medicine.medical_specialtyAbdominal painAcademicSubjects/MED00910medicine.medical_treatmentCase Report03 medical and health sciences0302 clinical medicinejscrep/080medicine030212 general & internal medicineMirizzi's syndromeEndoscopic retrograde cholangiopancreatographyCommon bile ductmedicine.diagnostic_testbusiness.industryGallbladderJaundicemedicine.diseaseSurgerymedicine.anatomical_structureCystic duct030211 gastroenterology & hepatologySurgeryCholecystectomymedicine.symptombusinessJournal of Surgical Case Reports
researchProduct

Guía de práctica clínica del síndrome del intestino irritable con estreñimiento y estreñimiento funcional en adultos: tratamiento. (Parte 2 de 2)

2017

En esta Guía de práctica clínica analizamos el manejo diagnóstico y terapéutico de pacientes adultos con estreñimiento y molestias abdominales, bajo la confluencia del espectro del síndrome del intestino irritable y el estreñimiento funcional. Ambas patologías están encuadradas en los trastornos funcionales intestinales y tienen una importante repercusión personal, sanitaria y social, afectando a la calidad de vida de los pacientes que las padecen. La primera es el subtipo de síndrome del intestino irritable en el que el estreñimiento es la alteración deposicional predominante junto con dolor abdominal recurrente, hinchazón y distensión abdominal frecuente. El estreñimiento se caracteriza p…

medicine.medical_specialtyAbdominal painConstipation03 medical and health scienceschemistry.chemical_compoundMolestia abdominal0302 clinical medicineBloatingInternal medicinemedicineEnfermedades digestivasAdultos030212 general & internal medicineLinaclotideIrritable bowel syndromeMedicine(all)Estreñimiento funcionallcsh:R5-920business.industrydigestive oral and skin physiologySíndrome del intestino irritablePublic Health Environmental and Occupational HealthAtención PrimariaGeneral MedicineAbdominal distensionmedicine.diseaseLubiprostoneGuía de práctica clínicachemistryRoma IVFunctional constipation030211 gastroenterology & hepatologymedicine.symptomlcsh:Medicine (General)Family Practicebusinessmedicine.drugAtención Primaria
researchProduct

Type 1A endoleak detachable coil embolization after endovascular aneurysm sealing: Case report

2021

Introduction Endovascular aneurysm sealing (EVAS) with the Nellix system was introduced to reduce endovascular aneurysm repair (EVAR) perioperative complications, especially endoleaks. Herein we report a case of successful type 1A endoleak managed with detachable coils embolization after EVAS. Presentation of case A 77-year-old male was referred for abdominal pain. The angio-CT scan confirmed the previous EVAS procedure and showed a type Is2 endoleak below the right renal artery resulting in a 2.5 cm aortic blister with contrast medium filling the space between the aortic wall and the endobags. The patient was considered unfit for conventional open surgery and an endovascular approach with …

medicine.medical_specialtyAbdominal painEndoleakmedicine.medical_treatmentCase ReportEndovascular aneurysm repairSettore MED/22 - Chirurgia Vascolare03 medical and health sciences0302 clinical medicineAneurysmMedicineLocal anesthesiaEmbolizationRight Renal Arterybusiness.industryCoil embolizationPerioperativemedicine.diseaseAneurysmSurgeryContrast medium030220 oncology & carcinogenesis030211 gastroenterology & hepatologySurgerymedicine.symptombusinessNellix
researchProduct

Recurrent intussusception of small bowel in a young patient due to metastases from cardiac undifferentiated pleomorphic sarcoma: A first ever case re…

2020

Highlights • Metastatic undifferentiated pleomorphic sarcoma (Malignant Fibrous Histiocytoma) is a rare entity in the visceral organs. • We report a case of a metastatic primary cardiac undifferentiated pleomorphic sarcoma which presented with a recurrent small bowel intussusception in a young man. • Laparotomy by a small midline incision performed on the same day identified an intussusception of a 15-cm section of small intestine caused by a 4-cm intraluminal metastasis from undifferentiated pleomorphic sarcoma. • Metastasis intussusception in the small intestine is a very rare condition and they are part of differential diagnosis in patient with a history of tumor who present with intussu…

medicine.medical_specialtyAbdominal painExploratory laparotomymedicine.medical_treatmentCase ReportCardiac Undifferentiated Pleomorphic SarcomaUndifferentiated Pleomorphic Sarcoma03 medical and health sciences0302 clinical medicineIntussusception (medical disorder)medicinebusiness.industryUndifferentiated pleomorphic sarcomamedicine.diseasePrimary tumor030220 oncology & carcinogenesis030211 gastroenterology & hepatologySurgeryRadiologySarcomamedicine.symptomSegmental resectionbusinessMalignant fibrous histiocytomaIntussusceptionCardiac sarcomaInternational Journal of Surgery Case Reports
researchProduct

Severity of irritable bowel syndrome in patients with temporomandibular disorders: A case-control study

2019

Background To assess the risk and severity of IBS in a population of TMD patients. Material and Methods Subjects for the study group were recruited from patients attending the Dental Clinic. Health controls (HC) were recruited among patients' friends and clinic staff. All subjects filled in the RDC/TMD questionnaire and the ROME III questionnaire for the diagnosis of IBS. The IBS Severity Scoring System (IBS-SSS) was used to evaluate the severity of each case of IBS. Categorical variables were compared through the Chi square test. The risk of having abdominal pain was analysed using logistic regression. Results Twenty-two (46.8%) cases of IBS were diagnosed among TMD patients, whereas only …

medicine.medical_specialtyAbdominal painScoring systemcase-control studyPopulationTemporomandibular disordersLogistic regressionNO03 medical and health sciences0302 clinical medicineInternal medicinemedicineChi-square testTemporomandibular disorders irritable bowel syndrome facial pain case-control studyIn patienteducationGeneral DentistryIrritable bowel syndromeirritable bowel syndromeeducation.field_of_studyOral Medicine and Pathologybusiness.industryResearchCase-control studymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Case-control study; Facial pain; Irritable bowel syndrome; Temporomandibular disordersstomatognathic diseasesUNESCO::CIENCIAS MÉDICAS030211 gastroenterology & hepatologymedicine.symptomfacial painbusiness030217 neurology & neurosurgery
researchProduct